ABJ Health Consulting Solutions, Inc. is a public health management consulting company dedicated to embracing healthy lifestyles and engaging healthy communities. Our goals are to increase the quality of health and well-being of individuals in local communities and to offer practical, cost-effective consulting solutions to our clients in capacity building, technical assistance, epidemiology and research. We seek partnerships with state and local health departments, ministries of health and global coalitions abroad.
Our dynamic team consists of epidemiologists, biostatisticians and consultants who work in public health, disease surveillance, infectious disease, non-communicable diseases and epidemiologic research.We offer guidance in epidemiology, disease surveillance, capacity building, public health practice, health services delivery, program management and evaluation, statistics, health education and training.
What Distinguishes Us?
- We focus on reducing individual risk factors among vulnerable populations by promoting and embracing healthy behaviors, healthy choices and lifestyles to reduce the burden of diseases.
- We advocate an evidence-based approach to policies and programs that address health disparities due to socioeconomic, cultural, geographical and environmental influences of health outcomes.
- We actively seek new health opportunities to promote community engagement and strategic partnerships.
- We have over 20 years’ experience in public health ranging from providing direct patient care and evaluating local and state health departments to epidemiology research.
President and Chief Executive Officer
Adelbert James, PhD, MPH, is the founder and chief executive officer at ABJ Health Consulting Solutions, Inc. He has over 20 years’ experience in public health, disease surveillance, health services and academia. Dr. James has served in various management level positions in public health. He began his public health career as a disease intervention specialist at sexually transmitted diseases and HIV clinics at local health departments in Florida. Later, he directed the tuberculosis control program and established tuberculosis surveillance programs at two local health departments in Florida and increased tuberculosis services to migrant populations. He provided consultation and technical assistance to infection control nurses and area physicians in tuberculosis control and prevention.
Adelbert B. James, PhD, MPH
Dr. James directed and coordinated the Chlamydia Project at Emory University School of Medicine and provided centralized project management, consultations and technical assistance in reducing chlamydia and gonorrhea infections among sexually active young women in eight southeastern states in the US. During his tenure: • He increased annual chlamydia and gonorrhea screening among sexually active young adults from 400,000 to 1 million. • Developed a self-training chlamydia and gonorrhea manual for health care providers and provided a certification for continuing education credits. • Initiated chlamydia awareness campaigns in collaboration with pharmaceuticals at 25 universities and colleges in 8 southeastern states. • Developed a strategic plan with state family planning directors, state STD program directors, state laboratory directors and community organizations to reduce the high prevalence of sexually transmitted diseases in the South.
He collaborated on several projects with the Center for Disease Control and Prevention, Office of Population Affairs, pharmaceutical companies, state family planning directors, state laboratories directors, STD program directors and community-based organizations.Dr. James recently served as an epidemiology researcher at the Center for Transfusion and Cellular Therapies at Emory University School of Medicine. His areas of interest were blood donor behaviors, identifying barriers and motivators to blood donor recruitment among African Americans and Hispanics and GIS. He is currently a faculty member at the University of Phoenix and teaches statistical applications.Dr. James holds a Master of Public Health degree in epidemiology and biostatistics from the University of South Florida and a PhD in health services and community health from Walden University. His doctoral dissertation was entitled Sociodemographic Patterns of Sexually Active Young Females with Recurrent Chlamydia Infections in Rural and Urban Environments.
Director of Epidemiology
Maria Rangel, MD, PhD is the director of epidemiology. She has more than 20 years’ experience in consulting on a broad range of public health issues. Her area of expertise includes grant writing, research, data analyses and teaching short courses for health professionals.Prior to joining ABJ Health Consulting Solutions, Inc., she served as the director of epidemiology for the Latin American region at GlaxoSmithKline Biologicals. She supervised an international team of epidemiologists in strategic planning, execution and evaluation of observational and experimental vaccines in Latin America.
Maria Rangel, MD, PhD
Dr. Rangel holds a MD degree from the University of Panama School of Medicine, a Masters of Public Health in epidemiology and biostatistics from the University of South Florida and a PhD in epidemiology from the University of North Carolina at Chapel Hill. Her doctoral dissertation was entitled Racial and Ethnic Disparities in Influenza Vaccination -The role of Access to Care.
Dr. Rangel has served as a senior epidemiologist at the CDC National Center for HIV, STD and TB Prevention and was responsible for providing technical assistance to states and US territories in the development, implementation and evaluation of HIV/AIDS surveillance. During her 14-year tenure at the Center for Disease Control and Prevention, she served as an epidemiologist in the Epidemiology and Surveillance Division, National Immunization Program, Adult Vaccine Preventable Division, the Office of Public Health Surveillance and Research, Division of Health Quality Promotion and the Surveillance Branch in Atlanta, GA.She has extensive experience in consulting for public health programs, including the Global Health Program in Central America, Pan American Health Organization’s expanded program on immunizations, malaria surveillance program and the development of a laboratory-based surveillance system for pneumococal pneumoniae invasive disease. She represented the US on a US-Mexico binational commission on aging and immunization.